Följ
Markus K. Dahlgren
Markus K. Dahlgren
Principal Scientist II, Schrodinger
Verifierad e-postadress på schrodinger.com
Titel
Citeras av
Citeras av
År
OPLS3: a force field providing broad coverage of drug-like small molecules and proteins
E Harder, W Damm, J Maple, C Wu, M Reboul, JY Xiang, L Wang, ...
Journal of chemical theory and computation 12 (1), 281-296, 2016
30072016
Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field
L Wang, Y Wu, Y Deng, B Kim, L Pierce, G Krilov, D Lupyan, S Robinson, ...
Journal of the American Chemical Society 137 (7), 2695-2703, 2015
12112015
OPLS3e: Extending force field coverage for drug-like small molecules
K Roos, C Wu, W Damm, M Reboul, JM Stevenson, C Lu, MK Dahlgren, ...
Journal of chemical theory and computation 15 (3), 1863-1874, 2019
9872019
OPLS4: Improving force field accuracy on challenging regimes of chemical space
C Lu, C Wu, D Ghoreishi, W Chen, L Wang, W Damm, GA Ross, ...
Journal of chemical theory and computation 17 (7), 4291-4300, 2021
9502021
Accurate binding free energy predictions in fragment optimization
TB Steinbrecher, M Dahlgren, D Cappel, T Lin, L Wang, G Krilov, R Abel, ...
Journal of chemical information and modeling 55 (11), 2411-2420, 2015
1402015
Reaction-based enumeration, active learning, and free energy calculations to rapidly explore synthetically tractable chemical space and optimize potency of cyclin-dependent …
KD Konze, PH Bos, MK Dahlgren, K Leswing, I Tubert-Brohman, ...
Journal of chemical information and modeling 59 (9), 3782-3793, 2019
1202019
Characterization of biaryl torsional energetics and its treatment in OPLS all-atom force fields
MK Dahlgren, P Schyman, J Tirado-Rives, WL Jorgensen
Journal of chemical information and modeling 53 (5), 1191-1199, 2013
1192013
Design, Synthesis, and Multivariate Quantitative Structure−Activity Relationship of SalicylanilidesPotent Inhibitors of Type III Secretion in Yersinia
MK Dahlgren, AM Kauppi, IM Olsson, A Linusson, M Elofsson
Journal of medicinal chemistry 50 (24), 6177-6188, 2007
912007
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia
MK Dahlgren, CE Zetterström, Å Gylfe, A Linusson, M Elofsson
Bioorganic & medicinal chemistry 18 (7), 2686-2703, 2010
782010
Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion
T Ur-Rehman, A Slepenkin, H Chu, A Blomgren, MK Dahlgren, ...
The Journal of antibiotics 65 (8), 397-404, 2012
412012
Virtual Screening and Optimization Yield Low-Nanomolar Inhibitors of the Tautomerase Activity of Plasmodium falciparum Macrophage Migration Inhibitory Factor
MK Dahlgren, A Baeza Garcia, AA Hare, J Tirado-Rives, L Leng, R Bucala, ...
Journal of medicinal chemistry 55 (22), 10148-10159, 2012
352012
Illuminating HIV gp120-ligand recognition through computationally-driven optimization of antibody-recruiting molecules
CG Parker, MK Dahlgren, RN Tao, DT Li, EF Douglass, T Shoda, ...
Chemical science 5 (6), 2311-2317, 2014
262014
Statistical molecular design of balanced compound libraries for QSAR modeling
A Linusson, M Elofsson, IE Andersson, MK Dahlgren
Current medicinal chemistry 17 (19), 2001-2016, 2010
262010
Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform
H Tang, K Jensen, E Houang, FM McRobb, S Bhat, M Svensson, ...
Journal of Medicinal Chemistry 65 (9), 6775-6802, 2022
192022
Synthesis of 2-(2-aminopyrimidine)-2, 2-difluoroethanols as potential bioisosters of salicylidene acylhydrazides
MK Dahlgren, CT Öberg, EA Wallin, PG Janson, M Elofsson
Molecules 15 (6), 4423-4438, 2010
152010
TYK2 inhibitors and uses thereof
CE Masse, JR Greenwood, DL Romero, GC Harriman, RT Wester, ...
US Patent 10,023,571, 2018
142018
Tyk2 inhibitors and uses thereof
M Dahlgren, JR Greenwood, GC Harriman, JJ Kennedy-smith, CE Masse, ...
US Patent App. 15/054,594, 2016
132016
TYK2 inhibitors and uses thereof
M Dahlgren, JR Greenwood, GC Harriman, JJ Kennedy-smith, CE Masse, ...
US Patent 10,253,046, 2019
122019
TYK2 inhibitors and uses thereof
CE Masse, JR Greenwood, DL Romero, GC Harriman, RT Wester, ...
US Patent 10,196,390, 2019
122019
Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase–dihydrofolate reductase
H Sharma, MJ Landau, TJ Sullivan, VP Kumar, MK Dahlgren, ...
Bioorganic & medicinal chemistry letters 24 (4), 1232-1235, 2014
102014
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20